Undifferentiated connective tissue disease pathophysiology: Difference between revisions
Line 8: | Line 8: | ||
===Pathogenesis=== | ===Pathogenesis=== | ||
[[File:52f75625e86e56001103e57adab227fd--invisible-illness-chronic-illness.jpg|thumb|left|200px]] | |||
[[File:52f75625e86e56001103e57adab227fd--invisible-illness-chronic-illness.jpg|thumb|200px]] | |||
*The exact pathogenesis of undifferentiated connective tissue disorder(UCTD) is not fully understood.<ref name="pmid10544849">{{cite journal |vauthors=Mosca M, Neri R, Bombardieri S |title=Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria |journal=Clin. Exp. Rheumatol. |volume=17 |issue=5 |pages=615–20 |date=1999 |pmid=10544849 |doi= |url=}}</ref> | *The exact pathogenesis of undifferentiated connective tissue disorder(UCTD) is not fully understood.<ref name="pmid10544849">{{cite journal |vauthors=Mosca M, Neri R, Bombardieri S |title=Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria |journal=Clin. Exp. Rheumatol. |volume=17 |issue=5 |pages=615–20 |date=1999 |pmid=10544849 |doi= |url=}}</ref> | ||
*It is understood that UCTD is the result of [[autoimmune]] process and occurs in phases.<ref name="pmid17530702">{{cite journal |vauthors=Bizzaro N, Tozzoli R, Shoenfeld Y |title=Are we at a stage to predict autoimmune rheumatic diseases? |journal=Arthritis Rheum. |volume=56 |issue=6 |pages=1736–44 |date=June 2007 |pmid=17530702 |doi=10.1002/art.22708 |url=}}</ref> | *It is understood that UCTD is the result of [[autoimmune]] process and occurs in phases.<ref name="pmid17530702">{{cite journal |vauthors=Bizzaro N, Tozzoli R, Shoenfeld Y |title=Are we at a stage to predict autoimmune rheumatic diseases? |journal=Arthritis Rheum. |volume=56 |issue=6 |pages=1736–44 |date=June 2007 |pmid=17530702 |doi=10.1002/art.22708 |url=}}</ref> |
Revision as of 20:13, 25 April 2018
Undifferentiated connective tissue disease Microchapters |
Differentiating Undifferentiated connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Undifferentiated connective tissue disease pathophysiology On the Web |
American Roentgen Ray Society Images of Undifferentiated connective tissue disease pathophysiology |
FDA on Undifferentiated connective tissue disease pathophysiology |
CDC on Undifferentiated connective tissue disease pathophysiology |
Undifferentiated connective tissue disease pathophysiology in the news |
Blogs on Undifferentiated connective tissue disease pathophysiology |
Directions to Hospitals Treating Undifferentiated connective tissue disease |
Risk calculators and risk factors for Undifferentiated connective tissue disease pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
Pathophysiology
Pathogenesis
- The exact pathogenesis of undifferentiated connective tissue disorder(UCTD) is not fully understood.[1]
- It is understood that UCTD is the result of autoimmune process and occurs in phases.[2]
- Initial phase: Asymptomatic and absence of auto-antibodies
- Second phase: Presence of auto-antibodies
- The second phase is usually triggered by the environmental factors, usually infection.
- Auto-antibodies appear before the symptoms of the disease.The time between the two is variable.
- Autoantibodies usually seen in UCTD with positive correlation are antibodies against:[3]
- C1q
- Anti heat shock protein(hsp)-65
- Anti hsp 60
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Mosca M, Neri R, Bombardieri S (1999). "Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria". Clin. Exp. Rheumatol. 17 (5): 615–20. PMID 10544849.
- ↑ Bizzaro N, Tozzoli R, Shoenfeld Y (June 2007). "Are we at a stage to predict autoimmune rheumatic diseases?". Arthritis Rheum. 56 (6): 1736–44. doi:10.1002/art.22708. PMID 17530702.
- ↑ Horváth L, Czirják L, Fekete B, Jakab L, Prohászka Z, Cervenak L, Romics L, Singh M, Daha MR, Füst G (January 2001). "Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases". Immunol. Lett. 75 (2): 103–9. PMID 11137133.